-
1
المؤلفون: Evan Y. Yu, Marinela Augustin, Josep M. Piulats, Charles Schloss, Johann S. de Bono, Christian Heinrich Poehlein, Mark Linch, Neal D. Shore, Emanuela Romano, Christophe Massard, Howard Gurney, Helen Wu, Anthony M. Joshua, Ali Tafreshi, Peter C.C. Fong, Joan Carles, Margitta Retz, Peter Hammerer
المصدر: Journal of Clinical Oncology. 37:5027-5027
مصطلحات موضوعية: Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, Castrate-resistant prostate cancer, Pembrolizumab, Olaparib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, Docetaxel, 030220 oncology & carcinogenesis, Internal medicine, Cohort, Medicine, Hormone therapy, business, 030215 immunology, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7a7efacfb1b9286b415d7c1227533fce
https://doi.org/10.1200/jco.2019.37.15_suppl.5027